Edison Investment Research - Euromax Resources Ltd. (EOX.) Update: Seamless strategy to FY16 funding and construction

Report

Edison Investment Research

Update: Seamless strategy to FY16 funding and construction

Further to its streaming deal in October, Euromax announced on 1 May
that it had mandated three banks plus Caterpillar Financial to provide up to
US$240m of project and equipment finance for the development of Ilovitza
at 2.75-3.25% above LIBOR. Moreover, it has confirmed that Ilovitza is also
eligible to participate in the German UFK scheme, whereby the German
government provides a direct guarantee to the banking consortium, which
then enables it to designate the loan as German sovereign risk rather than
project finance (thereby materially lowering the perceived risk).

14/05/2015 10 EN

Underlying

Euromax Resources Ltd.

See profile

CA29873T3073 Toronto Stock Exchange Canada

Provider

Edison Investment Research

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

See profile

Other Reports on these Companies

Vermilion Research

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

EUR 45.90

July 22, 2021 July 22, 2021 1 EN

GlobeNewsWire

Euromax Appoints new Chairman and Provides Corporate Update

Euromax Appoints new Chairman and Provides Corporate Update VANCOUVER, British Columbia, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Euromax Resources Ltd. (TSX: EOX): ("Euromax" or the "Company"), announces that it has appointed Tim Morgan-Wynne Non-Executive Chairman of the Company with immediate effect. Martyn Konig, the former Executive Chairman, will continue to serve as a Non-Executive Director of Euromax and is stepping down owing to other business commitments. Tim Morgan-Wynne joined the Company’s Board of Directors in June 2012 as Non-Executive Director and is also the Chairman of the A...

November 14, 2018 November 14, 2018 1 EN

GlobeNewsWire

Euromax Announces Results of Annual General Meeting

Euromax Announces Results of Annual General Meeting VANCOUVER, British Columbia, June 28, 2018 (GLOBE NEWSWIRE) -- Euromax Resources Ltd. (TSX:EOX): ("Euromax" or the "Company") is pleased to report that all resolutions proposed, as set out in the Notice of Meeting dated 22 May 2018, were duly passed at its Annual General Meeting held in London, UK on Thursday, June 28, 2018. At the Meeting, each of the individuals nominated by management for election as a director of the Company were duly elected and the number of directors of the Corporation was fixed at eight (8) in accordance with th...

June 28, 2018 June 28, 2018 1 EN

Basilea Pharmaceutica - Cresemba milestone payments continue to roll in

Basilea Pharmaceutica has announced the triggering of a US$1.25m milestone payment from Pfizer, triggered by sustained strong sales of Cresemba in the Asia-Pacific region and China. This is the second FY24 milestone payment for the region and is incremental to the payment received in March. We note that, according to the latest available data, total in-market sales of Cresemba amounted to US$473m in the 12 months ending December 2023, representing a +26% year-on-year increase. Basilea is preparing to launch its Phase III programme for fosmanogepix, a broad-spectrum antifungal therapy, with the...

May 17, 2024 May 17, 2024 1 EN

Toby Thorrington

Toby Thorrington

AAC Clyde Space - Solid start to the year with further order growth

AAC Clyde Space offers exposure to the fast-growing low Earth orbit space market. A solid start to the year and continued order momentum are encouraging. We also note the internal restructuring to promote delivery of the group’s products and services. We expect this combination to drive an improving performance, albeit within the lumpy nature of the business, in turn improving investor confidence and the stock’s valuation.

May 17, 2024 May 17, 2024 1 EN

Richard Williamson

Richard Williamson

Tinexta - Typical seasonality in Q124

Tinexta’s Q124 results showed good progress in the two divisions that typically demonstrate more consistent (through the year) growth, Cyber Security and Digital Trust, which management expects to deliver higher growth over the next few years. Business Innovation demonstrated its typical seasonality and management therefore remains confident about the outlook for the year.

May 17, 2024 May 17, 2024 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Update: Seamless strategy to FY16 funding and construction

Vermilion Short Shots: Technically Vulnerable Stocks

Euromax Appoints new Chairman and Provides Corporate Update

Euromax Announces Results of Annual General Meeting

Basilea Pharmaceutica - Cresemba milestone payments continue to roll in

AAC Clyde Space - Solid start to the year with further order growth

Tinexta - Typical seasonality in Q124

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe